aluminum hydroxide

Aluminum Hydroxide is an orally active primary form of aluminum used as an adjuvant. Research on aluminum hydroxide-based adjuvants includes examining its repository effect, pro-phagocytic effect, and activation of the pro-inflammatory NLRP3 pathway.

Aluminum hydroxideadjuvant is a vaccine adjuvant. In vitro, aluminum hydroxideadjuvant can induce macrophages to differentiate into a novel type of mature, specialized antigen-presenting cells.

Sucralox is a sugar-complexed aluminum hydroxide with antacid properties.

TLR7 agonist24 (Compound 21) is an agonist of TLR7 with an EC50 of 3.72 μM. When combined with Aluminum Hydroxide, it can be employed as a vaccine adjuvant to enhance the immune response to antigens from SARS-CoV-2 and hepatitis B.

AADvac 1 TFA is an active tau peptide vaccine utilized in Alzheimer's disease research. It is formed by conjugating the regulatory peptide 294KDNIKHVPGGGS305, which drives tau oligomerization, with keyhole limpet hemocyanin (KLH), and is formulated with aluminum hydroxide.